Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Mesenchymal Stem/Stromal Cell-Derived Exosomes in Regenerative Medicine and Cancer; Overview of Development, Challenges, and Opportunities Publisher Pubmed



Hassanzadeh A1 ; Rahman HS2 ; Markov A3 ; Endjun JJ4, 5 ; Zekiy AO6 ; Chartrand MS7 ; Beheshtkhoo N8 ; Kouhbanani MAJ8 ; Marofi F9 ; Nikoo M10 ; Jarahian M11
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Applied Cell Sciences, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Department of Physiology, College of Medicine, University of Suleimanyah, Sulaymaniyah, Iraq
  3. 3. Tyumen State Medical University, Tyumen, Russian Federation
  4. 4. Medical Faculty, UPN Veteran, Jakarta, Indonesia
  5. 5. Gatot Soebroto Indonesia Army Hospital, Jakarta, Indonesia
  6. 6. Sechenov First Moscow State Medical University, Moscow, Russian Federation
  7. 7. DigiCare Behavioral Research, Casa Grande, AZ, United States
  8. 8. Department of Medical Nanotechnology, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Shiraz, Iran
  9. 9. Immunology Research Center (IRC), Tabriz University of Medical Sciences, Tabriz, Iran
  10. 10. Department of Immunology, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran
  11. 11. Toxicology and Chemotherapy Unit (G401), German Cancer Research Center, Heidelberg, 69120, Germany

Source: Stem Cell Research and Therapy Published:2021


Abstract

Recently, mesenchymal stem/stromal cells (MSCs) and their widespread biomedical applications have attracted great consideration from the scientific community around the world. However, reports have shown that the main populations of the transplanted MSCs are trapped in the liver, spleen, and lung upon administration, highlighting the importance of the development of cell-free therapies. Concerning rising evidence suggesting that the beneficial effects of MSC therapy are closely linked to MSC-released components, predominantly MSC-derived exosomes, the development of an MSC-based cell-free approach is of paramount importance. The exosomes are nano-sized (30–100 nm) lipid bilayer membrane vesicles, which are typically released by MSCs and are found in different body fluids. They include various bioactive molecules, such as messenger RNA (mRNA), microRNAs, proteins, and bioactive lipids, thus showing pronounced therapeutic competence for tissues recovery through the maintenance of their endogenous stem cells, the enhancement of regenerative phenotypic traits, inhibition of apoptosis concomitant with immune modulation, and stimulation of the angiogenesis. Conversely, the specific roles of MSC exosomes in the treatment of various tumors remain challenging. The development and clinical application of novel MSC-based cell-free strategies can be supported by better understanding their mechanisms, classifying the subpopulation of exosomes, enhancing the conditions of cell culture and isolation, and increasing the production of exosomes along with engineering exosomes to deliver drugs and therapeutic molecules to the target sites. In the current review, we deliver a brief overview of MSC-derived exosome biogenesis, composition, and isolation methods and discuss recent investigation regarding the therapeutic potential of MSC exosomes in regenerative medicine accompanied by their double-edged sword role in cancer. © 2021, The Author(s).
Other Related Docs
14. Exosomes and Micrornas in Biomedical Science, Synthesis Lectures on Biomedical Engineering (2022)
21. Exosomal Micrornas in Regulation of Tumor Cells Resistance to Apoptosis, Biochemistry and Biophysics Reports (2024)
37. Exosomes in Cancer Liquid Biopsy: A Focus on Breast Cancer, Molecular Therapy Nucleic Acids (2018)
45. Exosomes: Friends or Foes in Microbial Infections?, Infectious Disorders - Drug Targets (2024)